FI842457A0 - 1-alkyl-androsta-1,4-dien-3,17-dioner, deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska produkter. - Google Patents

1-alkyl-androsta-1,4-dien-3,17-dioner, deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska produkter.

Info

Publication number
FI842457A0
FI842457A0 FI842457A FI842457A FI842457A0 FI 842457 A0 FI842457 A0 FI 842457A0 FI 842457 A FI842457 A FI 842457A FI 842457 A FI842457 A FI 842457A FI 842457 A0 FI842457 A0 FI 842457A0
Authority
FI
Finland
Prior art keywords
androsta
alkyl
dioner
dien
pharmaceutical product
Prior art date
Application number
FI842457A
Other languages
English (en)
Other versions
FI81361C (fi
FI842457A (fi
FI81361B (fi
Inventor
Ulrich Kerb
Gerhard Sauer
Rudolf Wiechert
David Henderson
Yukishige Nishino
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI842457A0 publication Critical patent/FI842457A0/fi
Publication of FI842457A publication Critical patent/FI842457A/fi
Priority to FI901031A priority Critical patent/FI84487C/fi
Application granted granted Critical
Publication of FI81361B publication Critical patent/FI81361B/fi
Publication of FI81361C publication Critical patent/FI81361C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI842457A 1983-06-18 1984-06-18 Foerfarande foer framstaellning av terapeutiskt aktiva 1-alkyl-androsta-1,4-dien-3,17-dioner. FI81361C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI901031A FI84487C (fi) 1983-06-18 1990-03-01 1-alkyl-androsta-1,4-dien-3, 17-dioner som anvaends foer kontraseption och en komposition innehaollande desamma.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3322285 1983-06-18
DE3322285A DE3322285A1 (de) 1983-06-18 1983-06-18 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate

Publications (4)

Publication Number Publication Date
FI842457A0 true FI842457A0 (fi) 1984-06-18
FI842457A FI842457A (fi) 1984-12-19
FI81361B FI81361B (fi) 1990-06-29
FI81361C FI81361C (fi) 1990-10-10

Family

ID=6201972

Family Applications (1)

Application Number Title Priority Date Filing Date
FI842457A FI81361C (fi) 1983-06-18 1984-06-18 Foerfarande foer framstaellning av terapeutiskt aktiva 1-alkyl-androsta-1,4-dien-3,17-dioner.

Country Status (19)

Country Link
US (1) US4591585A (fi)
EP (1) EP0129500B1 (fi)
JP (1) JPS6013796A (fi)
AT (1) ATE28752T1 (fi)
AU (1) AU562646B2 (fi)
CA (1) CA1223251A (fi)
DD (1) DD218623A5 (fi)
DE (2) DE3322285A1 (fi)
DK (1) DK158358C (fi)
ES (1) ES8502709A1 (fi)
FI (1) FI81361C (fi)
GR (1) GR82160B (fi)
HU (1) HU189415B (fi)
IE (1) IE57621B1 (fi)
IL (1) IL72067A (fi)
NO (1) NO159278C (fi)
NZ (1) NZ208552A (fi)
PT (1) PT78743B (fi)
ZA (1) ZA844603B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275936A (en) * 1985-04-03 1994-01-04 Schering Aktiengesellschaft Process for the preparation of 1-methyl-1,4-androstadiene-3,17-dione
DE3512328A1 (de) * 1985-04-03 1987-03-19 Schering Ag Verahren zur herstellung von 1-methyl-1,4-androstadien-3,17-dion
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones
DE3539244A1 (de) * 1985-11-01 1987-05-07 Schering Ag 1-methyl-15(alpha)-alkyl-androsta- 1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
GB8617107D0 (en) * 1986-07-14 1986-08-20 Erba Farmitalia 6-/7-methylenandrosta-1 4-diene-3 17-dione derivatives
DE3703722A1 (de) * 1987-02-04 1988-08-18 Schering Ag 1-methyl-15(alpha)-(1,2-dialkanoyloxyalkyl)-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3705990A1 (de) * 1987-02-20 1988-09-01 Schering Ag 1-methyl-15(alpha)-(1-oxyalkyl)-androsta-1,4-dien- 3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3715869A1 (de) * 1987-05-07 1988-11-17 Schering Ag Verfahren zur herstellung von 1-methyl-androsta-1,4-dien-3,17-dion und die neuen zwischenprodukte fuer dieses verfahren
GB8720856D0 (en) * 1987-09-04 1987-10-14 Emi Plc Thorn Matrix addressing
EP0310542B1 (de) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren
EP0582713B1 (en) * 1991-03-28 1997-06-04 Teikoku Hormone Mfg. Co., Ltd. -New D-homo-17-oxa and D-homo-17-aza-androstane derivatives
NZ256130A (en) * 1992-09-30 1996-05-28 Teikoku Hormone Mfg Co Ltd 7-substituted oxasteroid derivatives; pharmaceutical compositions
GB9222669D0 (en) * 1992-10-28 1992-12-09 Erba Carlo Spa 6,7 alpha-difluoromethylenandrosta-1,4-dien-3-one derivatives and process for their preparation
DE4435368A1 (de) * 1994-09-22 1996-03-28 Schering Ag Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann
WO1996015253A1 (de) * 1994-11-14 1996-05-23 Schering Aktiengesellschaft Verfahren zur herstellung von 1-hydroxymethyl-1.4-androstadien-3.17-dion
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
EP0943333A1 (de) * 1998-03-18 1999-09-22 S.W. Patentverwertungs GmbH Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3006929A (en) * 1957-09-24 1961-10-31 Searle & Co 1-methyl-17-alkyl-19-nortestosterones
DE1174776B (de) * 1962-08-04 1964-07-30 Schering Ag Verfahren zur Herstellung von 1ª‡, 7ª‡-Dimethyl-steroiden der Androstanreihe
DE1174778B (de) * 1962-08-16 1964-07-30 Schering Ag Verfahren zur Herstellung von 3, 4-Dimethyl-?-oestratrien-1, 17ª‰-diol
DE1249268B (de) * 1964-12-02 1967-09-07 Schermg Aktiengesellschaft, Berlin Verfahren zur Herstellung von 1 7a-Dimethyl - A1 - androstcnolondenvaten
DE2943776A1 (de) * 1979-10-26 1981-05-14 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17 (alpha) -alkylsteroide, diese enthaltende praeparate sowie verfahren zu ihrer herstellung
US4474701A (en) * 1983-03-10 1984-10-02 Veb Jenapharm Jena Process for the separation of 4-androsten-3,17-dione and 1,4-androstadien-3,17-dione

Also Published As

Publication number Publication date
ATE28752T1 (de) 1987-08-15
EP0129500A2 (de) 1984-12-27
IL72067A (en) 1987-08-31
IE57621B1 (en) 1993-02-10
FI81361C (fi) 1990-10-10
DK158358C (da) 1990-10-08
PT78743B (de) 1986-07-14
JPH0132235B2 (fi) 1989-06-29
NO842408L (no) 1984-12-19
ES533261A0 (es) 1985-02-01
EP0129500B1 (de) 1987-08-05
DE3322285A1 (de) 1984-12-20
DK158358B (da) 1990-05-07
HU189415B (en) 1986-07-28
IE841494L (en) 1984-12-18
EP0129500A3 (en) 1985-05-15
ES8502709A1 (es) 1985-02-01
FI842457A (fi) 1984-12-19
HUT34513A (en) 1985-03-28
PT78743A (de) 1984-07-01
CA1223251A (en) 1987-06-23
GR82160B (fi) 1984-12-13
JPS6013796A (ja) 1985-01-24
DD218623A5 (de) 1985-02-13
US4591585A (en) 1986-05-27
DK282784A (da) 1984-12-19
NZ208552A (en) 1986-11-12
AU2939984A (en) 1984-12-20
FI81361B (fi) 1990-06-29
DK282784D0 (da) 1984-06-08
AU562646B2 (en) 1987-06-18
NO159278B (no) 1988-09-05
ZA844603B (en) 1985-02-27
IL72067A0 (en) 1984-10-31
NO159278C (no) 1988-12-14
DE3465201D1 (en) 1987-09-10

Similar Documents

Publication Publication Date Title
FI842457A (fi) 1-alkyl-androsta-1,4-dien-3,17-dioner, deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska produkter.
DK623784A (da) 11beta-aryloestradiener, fremgangsmaader til fremstilling heraf og farmaceutiske praeparater med indhold heraf
DK163209C (da) To- eller tretrinskombinationspraeparat til oral kontraception
ES506742A0 (es) Procedimiento para la preparacion de 11-metilen- 15-esteroi-des
IT8083420A0 (it) Derivati d'amino-14 steroidi e procedimento per la loro preparazione.
DK146785D0 (da) Pharmaceutisk praeparat med indhold af 9alfa, 11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion
PT86228A (de) Verfahren zur herstellung von 6alpha,9alpha-difluor-11beta,17alpha-dihydroxy-16alpha-methil-4-pregnen-3,20-dion und dessen derivate
DK92183D0 (da) 11beta-chlor-delta15-steroider, fremgangsmade til fremstilling heraf og farmaceutiske praeparater med indhold heraf
MX9100291A (es) Nuevos derivados de la 6-metil 19-nor progesterona,substituidos en 3 y su procedimiento de obtencion
AU2695377A (en) Medicinal composition for the treatment of biliary lithiasis
DE2861474D1 (en) Novel delta-4,9-pregnane derivatives, their use as progestational and/or ovulation-inhibiting agents and process for their preparation
PT77880A (de) Neue 6alpha-methylprednisolon-derivate ihre herstellung und verwendung
ATE971T1 (de) Hydrocortison-orthoester, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
MA Patent expired

Owner name: SCHERING AKTIENGESELLSCHAFT